Profile
Danilo Piroli currently works at Chiesi Ltd., as Director from 1999.
Mr. Piroli also formerly worked at Zymenex A, as Director, CHIESI Farmaceutici SpA, as Director-Corporate Finance, and Chiesi SAS, as Director.
Danilo Piroli active positions
| Companies | Position | Start |
|---|---|---|
Chiesi Ltd.
Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Director/Board Member | 2011-02-02 |
Former positions of Danilo Piroli
| Companies | Position | End |
|---|---|---|
Chiesi SAS
Chiesi SAS Pharmaceuticals: GenericHealth Technology Wholesales and distributes pharmaceutical products | Director/Board Member | - |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Director/Board Member | - |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Director of Finance/CFO | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Chiesi SAS
Chiesi SAS Pharmaceuticals: GenericHealth Technology Wholesales and distributes pharmaceutical products | Health Technology |
Chiesi Ltd.
Chiesi Ltd. Pharmaceuticals: MajorHealth Technology Develops, markets and supplies therapeutic products | Health Technology |
- Stock Market
- Insiders
- Danilo Piroli
















